Literature DB >> 19645833

Lack of evidence of pregnancy-induced alloantibodies in dogs.

M-C Blais1, E A Rozanski, A S Hale, S P Shaw, S M Cotter.   

Abstract

BACKGROUND: It is controversial whether or not pregnant bitches become sensitized to red blood cell (RBC) antigens. HYPOTHESIS: Bitches do not develop alloantibodies to RBC antigens during gestation and can be used safely as blood donors. ANIMALS: The study group included 35 healthy female dogs with a prior history of 1 (n = 12), 2 (n = 14), or >or= 3 (n = 9) pregnancies. The control group consisted of 15 healthy female dogs without any history of pregnancy.
METHODS: All dogs were blood typed for dog erythrocyte antigens (DEA) 1.1, 1.2, 3, 4, 5, and 7 using ethylenediaminetetraacetic acid blood samples and polyclonal antisera. Antibody screening was performed with serum and canine RBC panels of known blood type. An autocontrol and direct antiglobulin test were performed to rule out the presence of autoantibodies.
RESULTS: The only alloantibodies identified were those against DEA 7 and the prevalence of anti-DEA 7 alloantibodies was similar in dogs with known history of pregnancy (11.4%) and in the control group (13.3%). CONCLUSIONS AND CLINICAL IMPORTANCE: These results confirm previous studies and clinical transfusion medicine experience. Naturally occurring anti-DEA 7 alloantibodies have been reported but their clinical relevance has not been shown. Pregnancy does not appear to sensitize dogs to RBC antigens. Consequently, dogs with prior history of pregnancy can be used safely as blood donors. Conversely, no additional pretransfusion compatibility studies would be required should these dogs themselves need to be transfused.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19645833     DOI: 10.1111/j.1939-1676.2009.0286.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  7 in total

1.  Dog erythrocyte antigens 1.1, 1.2, 3, 4, 7, and Dal blood typing and cross-matching by gel column technique.

Authors:  Rebecca J Kessler; Jessica Reese; Denise Chang; Mayank Seth; Anne S Hale; Urs Giger
Journal:  Vet Clin Pathol       Date:  2010-08-18       Impact factor: 1.180

2.  Pre- and Post-Transfusion Alloimmunization in Dogs Characterized by 2 Antiglobulin-Enhanced Cross-match Tests.

Authors:  I Goy-Thollot; U Giger; C Boisvineau; R Perrin; M Guidetti; B Chaprier; A Barthélemy; C Pouzot-Nevoret; B Canard
Journal:  J Vet Intern Med       Date:  2017-08-14       Impact factor: 3.333

3.  Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies.

Authors:  Jae Ho Lee; Urs Giger; Hee Young Kim
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

4.  Prevalence of Dog Erythrocyte Antigen 1 in 7,414 Dogs in Italy.

Authors:  Anyela Andrea Medina Valentin; Alessandra Gavazza; George Lubas
Journal:  Vet Med Int       Date:  2017-09-24

5.  ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

Authors:  Oliver A Garden; Linda Kidd; Angela M Mexas; Yu-Mei Chang; Unity Jeffery; Shauna L Blois; Jonathan E Fogle; Amy L MacNeill; George Lubas; Adam Birkenheuer; Simona Buoncompagni; Julien R S Dandrieux; Antonio Di Loria; Claire L Fellman; Barbara Glanemann; Robert Goggs; Jennifer L Granick; Dana N LeVine; Claire R Sharp; Saralyn Smith-Carr; James W Swann; Balazs Szladovits
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

6.  Prevalence of Dal blood type and dog erythrocyte antigens (DEA) 1, 4, and 7 in canine blood donors in Italy and Spain.

Authors:  Daniela Proverbio; George Lubas; Eva Spada; Anyela Andrea Medina Valentin; Luis Miguel Viñals Florez; Maria Del Rosario Perlado Chamizo; Roberta Perego; Maria Grazia Pennisi; Elisabetta Ferro; Luciana Baggiani; Alessandra Gavazza; Marie-Claude Blais
Journal:  BMC Vet Res       Date:  2020-05-06       Impact factor: 2.741

7.  Accuracy of point-of-care crossmatching methods and crossmatch incompatibility in critically ill dogs.

Authors:  Hayden Marshall; Shauna L Blois; Anthony C G Abrams-Ogg; Alexa M Bersenas; Kristiina Ruotsalo; Gabrielle Monteith
Journal:  J Vet Intern Med       Date:  2020-12-18       Impact factor: 3.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.